Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction

Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction

OBJECTIVES: To investigate the acute effect of phosphodiesterase type 5 (PDE5) inhibitor on erectile dysfunction by evaluating serum oxidative status and prolidase activity. METHODS: Serum samples of 36 patients with erectile dysfunction and 30 control cases were analyzed for total antioxidant statu...

Full description

Bibliographic Details
Main Authors:	Murat Savas, Ercan Yeni, Ayhan Verit, Mehmet Gulum, Nurten Aksoy, Halil Ciftci, Hakim Celik, Adem Altunkol, Halil Oncel
Format:	Article
Language:	English
Published:	Faculdade de Medicina / USP 2010-01-01
Series:	Clinics
Subjects:	Phosphodiesterase type 5 inhibitors Tadalafil citrate Total antioxidant status Total oxidant status Prolidase
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200014

Similar Items

Association of Tissue Transglutaminase with Nerve Growth Factor, Prolidase Activity and Oxidative Stress in Celiac Patients
by: Akhilesh Kumar Verma, et al.
Published: (2018-11-01)

No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
by: Jenny Z. Wang, et al.
Published: (2019-09-01)

Prolidase Activity and Oxidative Stress in Patients with Glioma
by: Akhilesh Kumar Verma, et al.
Published: (2018-10-01)

Expression of human prolidase in E. coli : kinetic and metal binding properties
by: Carriles, Claudia.
Published: (1998)

Catalytic properties and mechanism studies of the PepQ prolidase from Escherichia coli
by: Park, Min Sun
Published: (2006)

PROLIDASE: A Review from Discovery to its Role in Health and Disease
by: Ireti Eni-Aganga, et al.
Published: (2021-08-01)

The molecular basis of prolidase deficiency /
by: Ledoux, Pierre, 1964.
Published: (1996)

Prolidase deficiency
by: Masood Qazi, et al.
Published: (2007-01-01)

Antioxidant Status and Serum Prolidase Activity in Women with Subclinical Hypothroidism
by: Mehmet Ali Eren, et al.
Published: (2015-06-01)

Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
by: Yatan Pal Singh Balhara, et al.
Published: (2015-01-01)

Prolidase activity in major depressive disorder
by: Süleyman Demir, et al.
Published: (2015-09-01)

Gingival Crevicular Fluid Levels of Prolidase and Alkaline Phosphatase in Periodontitis
by: Guven Berrak, et al.
Published: (2017-11-01)

Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants
by: Kira Süßmuth, et al.
Published: (2020-01-01)

Evaluation of serum prolidase enzyme activity and oxidative stress in patients with tinnitus
by: Adnan Ekinci, et al.
Published: (2020-07-01)

The Importance of Serum Prolidase Activity in Endometriosis
by: Mukaddes Demir Dural, et al.
Published: (2019-08-01)

Current Understanding of the Emerging Role of Prolidase in Cellular Metabolism
by: Magdalena Misiura, et al.
Published: (2020-08-01)

Serum prolidase activity in patients with cardiac syndrome X
by: Gonul Aciksari, et al.
Published: (2020-10-01)

Phosphodiesterase-5 inhibitors: Raynaud's and beyond
by: Sanat Phatak, et al.
Published: (2017-01-01)

The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease
by: Natsumi Tomita, et al.
Published: (2020-09-01)

Bilateral compartment of the hands in prolidase deficiency syndrome
by: Raphael Tasar, et al.
Published: (2021-09-01)

Doença Metabólica Rara. Deficiência em Prolidase
by: J. Silva Pereira, et al.
Published: (2014-09-01)

Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
by: Aiste‐Monika Jakstaite, et al.
Published: (2021-08-01)

Cloning, expression, and characterization of lactic acid bacteria recombinant prolidases
by: Yang, Soo In
Published: (2007)

Chitotirosidase and prolidase in tinea pedis: A preliminary study
by: Halef Okan Dogan, et al.
Published: (2018-03-01)

Clinical Genetics of Prolidase Deficiency: An Updated Review
by: Marta Spodenkiewicz, et al.
Published: (2020-05-01)

Circulating Prolidase Activity in Patients with Myocardial Infarction
by: Adnan Sultan, et al.
Published: (2017-07-01)

High prolidase levels in patients with Familial Mediterranean Fever (FMF)
by: Bayram Meliha, et al.
Published: (2020-03-01)

Serum levels of prolidase and ischemia modified albumin in patients with multiple sclerosis
by: Mehmet Uğur Çevik, et al.
Published: (2012-12-01)

The serum prolidase enzyme activity as a biomarker for evaluation of the subclinical vascular damage in children with epilepsy
by: Nurettin Karacan, et al.
Published: (2020-01-01)

The Relations between Enuresis in Childhood and Nocturnal Polyuria Syndrome in Adult Life
by: Halil Ciftci, et al.
Published: (2012-03-01)

Prolidase Stimulates Proliferation and Migration Through Activation of the PI3K/Akt/mTOR Signaling Pathway in Human Keratinocytes
by: Magdalena Misiura, et al.
Published: (2020-12-01)

Isolation of Prolidase from Amniotic Fluid and Study of its Kinetic and Affinity Properties Towards Pharmacological Compounds
by: Luay Al-Helaly
Published: (2019-09-01)

Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
by: Faruk Kucukdurmaz, et al.
Published: (2017-12-01)

Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
by: Bang-Ping Jiann
Published: (2016-06-01)

Platelet-Rich Plasma Promotes the Proliferation of Human Keratinocytes via a Progression of the Cell Cycle. A Role of Prolidase
by: Magdalena Misiura, et al.
Published: (2021-01-01)

The contributions of S<sub>1</sub> site residues to substrate specificity and allosteric behaviour of <i>Lactococcus lactis</i> prolidase
by: Hu, Keke
Published: (2009)

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial
by: Shintaro Maki, et al.
Published: (2019-06-01)

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
by: Lee LK, et al.
Published: (2016-07-01)

Brain morphological defects in prolidase deficient mice: first report
by: V. Insolia, et al.
Published: (2014-09-01)

Assessment of Serum Ischemia-modified albumin, Prolidase and Thiol-Disulphide Levels in Subjects With Breast Cancer
by: Abusoglu Sedat, et al.
Published: (2019-01-01)